Informing patients about biosimilar medicines: the role of european patient associations

HIGHLIGHTS

  • who: Yannick Vandenplas et al. from the Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, BelgiumHospital Pharmacy, Erasmus University Medical Center, GD Rotterdam, The Netherlands have published the research work: Informing Patients about Biosimilar Medicines: The Role of European Patient Associations, in the Journal: Pharmaceuticals 2021, 14, 117. of /2021/
  • what: Review, an overview of the important aspects when talking to patients about biosimilars is provided for policymakers, healthcare providers, patient organizations, and other relevant stakeholders, in support of a sustainable market for off-patent biological and biosimilar medicines in Europe. Instead, the article . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?